Search

The outsourcing of comprehensive genomic profiling (CGP) testing in oncology has proven to improve patient eligibility for personalized therapies, while ensuring quality, adherence to timelines, and savings for the healthcare system. #OncologiaDiPrecisione #TestGenomici #MolecularTumorBoard (translated)

A new antibody-drug, referred to as a Trojan horse, has been shown to reduce the risk of death by 42% in patients with Claudina 18.2 positive stomach cancer, with a 53% reduction in more advanced cases, according to a study presented at the congress of the European Society for Medical Oncology. #TumoreGastrico #OncologiaDiPrecisione #AnticorpoFarmaco (translated)